FDA Inspection 1293824 — Pawel Brzewski
The FDA completed an inspection of Pawel Brzewski on November 14, 2025 in Cracow. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 14, 2025
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Cracow (Poland)
Additional Details
Clinical Investigator (CI)